Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.105 | 34.4262295082 | 0.305 | 0.42 | 0.3013 | 888674 | 0.3583383 | CS |
| 4 | -0.05001 | -10.8715027934 | 0.46001 | 0.5566 | 0.3013 | 969079 | 0.40486758 | CS |
| 12 | -0.14 | -25.4545454545 | 0.55 | 0.83 | 0.3013 | 622427 | 0.49553561 | CS |
| 26 | -0.9 | -68.7022900763 | 1.31 | 1.44 | 0.3013 | 610749 | 0.70121999 | CS |
| 52 | -2.59 | -86.3333333333 | 3 | 4.17 | 0.3013 | 823294 | 1.91856333 | CS |
| 156 | -22.31 | -98.1954225352 | 22.72 | 34.125 | 0.3013 | 1020132 | 7.61552969 | CS |
| 260 | -9.58 | -95.8958958959 | 9.99 | 74.89 | 0.3013 | 801385 | 15.14256419 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
